Newmont Corporation
NYSE:NEMGold
-$2.45 today
- Market cap
- $108.63B
- Beta
- 0.46
- P/E (TTM)
- 13.2
- EPS (TTM)
- $7.79
- Dividend yield
- 0.99%
Volume 8.52M
Average 8.93M
NEM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Newmont CorporationNYSE: NEM
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $58M rose 45.0% year over year, ahead of the +12.9% change in trailing-twelve-month research & development. Sequentially, it rose 23.4% from the prior quarter. Over 3 fiscal years it compounded at -10.2% a year.
Context
- Research & development amounted to 0.7% of revenue in FY2025, down 0.3 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +45.0% holds above the trailing-twelve-month pace of +12.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 166M USD
- Year-over-year change
- -15.7%
- 4-year CAGR
- +1.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 166M | -15.7% |
| FY2024 | 2024-12-31 | 197M | -1.5% |
| FY2023 | 2023-12-31 | 200M | -12.7% |
| FY2022 | 2022-12-31 | 229M | +48.7% |
| FY2021 | 2021-12-31 | 154M | — |
Research & Development vs competitors
How NEM compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +12.9% is the highest of 2, against a peer median of -100.0%.
- Research & development amounts to 0.7% of revenue for NEM, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $193M USD | +12.9% | -10.2% | 0.7% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| FY2026 | ZAR 0 ZAR | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NEM) | — | -100.0% | — | 0.0% | |
Competitors are the stored peer set for NEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.19B | 11.95B | 11.78B | 18.56B | 22.67B |
| Cost of Revenue | 9.81B | 9.81B | 10.61B | 12.13B | 10.61B |
| Gross Profit | 2.38B | 2.14B | 1.17B | 6.42B | 12.06B |
| Gross Margin | 19.5% | 17.9% | 9.9% | 34.6% | 53.2% |
| Research & Development | 154M | 229M | 200M | 197M | 166M |
| Selling, General & Admin | 259M | 276M | 299M | 442M | 382M |
| Operating Expenses | 460M | 523M | 520M | 676M | 1.04B |
| Depreciation & Amortization | 2.32B | 2.19B | 2.11B | 2.58B | 2.52B |
| EBITDA | 3.7B | 2.36B | 325M | 7.54B | 14.09B |
| EBITDA Margin | 30.3% | 19.8% | 2.8% | 40.6% | 62.2% |
| Operating Income | 1.92B | 1.62B | 650M | 5.75B | 11.02B |
| Operating Margin | 15.7% | 13.6% | 5.5% | 31.0% | 48.6% |
| Interest Income | 18M | 78M | 148M | 152M | 214M |
| Interest Expense | 266M | 227M | 248M | 385M | 229M |
| Other Income / Expenses | (642M) | (1.57B) | (2.62B) | (1.04B) | 740M |
| Income Before Tax | 1.27B | 56M | (1.97B) | 4.71B | 11.76B |
| Pre-Tax Margin | 10.5% | 0.5% | -16.7% | 25.4% | 51.9% |
| Income Tax Expense | 1.1B | 455M | 526M | 1.4B | 4.6B |
| Net Income | 1.17B | (459M) | (2.52B) | 3.35B | 7.09B |
| Net Margin | 9.6% | -3.8% | -21.4% | 18.0% | 31.3% |
| EPS (Basic) | 1.46 | (0.58) | (3.00) | 2.86 | 6.41 |
| EPS (Diluted) | 1.46 | (0.58) | (3.00) | 2.86 | 6.41 |
| Weighted Avg Shares | 799M | 794M | 841M | 1.15B | 1.11B |
| Weighted Avg Shares (Diluted) | 801M | 795M | 841M | 1.15B | 1.11B |
Newmont Corporation
NYSE:NEM
Intrinsic Alpha fair value
Locked
Current Price
$104.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.